Tirzepatide (Mounjaro) is a brand spanking new drug on the market that is being used for both diabetes and weight loss. It is in a class of drugs known as dual incretin agonists, affectionately called “twincreatins” because they act on the receptors for two hunger hormones GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).
At Elam Health and Wellness, Dr. Stephanie Opusunju offers personalized and state of the art weight management. To learn more, contact the office in Dallas, Texas or request an appointment online.
To get an idea of just how effective Mounjaro is let's examine the results of a study published in the New England Journal of Medicine. The study, known as SURMOUNT-1, was a placebo controlled trial with over 2500 obese participants. It found that the average weight loss with Mounjaro was an astounding 22.5%, far more than any weight loss drug on the market and even rivaling the results seen in bariatric surgery.
When you compare Mounjaro with other weight loss medications in its class including semaglutide, which is sold under the brand names Ozempic, Rybelsus and Wegovy, and the longer acting versions such as liraglutide (Victoza, Saxenda), dulaglutide (Trulicity) and exenatide (Byetta, Bydureon), Mounjaro blows all of them out of the water. Unlike these other medications. Mounjaro is yielding greater weight loss by being the only of its kind to stimulate two satiety hormone receptors (GLP-1 and GIP) instead of just one (GLP-1).
The most common side effects of tirzepatide are the same as the GLP-1 medications; primary gastrointestinal symptoms like nausea or vomiting and diarrhea or constipation. Most side effects are temporary occuring during the initiation phase and can be alleviated by starting at the lowest dose and slowly increasing over time.
When new medications hit the market, insurance coverage is always tricky. Right now Mounjaro is only approved for use in patients with a documented diagnosis of diabetes and treatment failures of other diabetes medications. As we wait for approval for the weight loss indication, we can take advantage of the $25 savings card Mounjaro is offering for patients with type 2 diabetes diagnosis and commercial insurance.
The best weight loss results are a combination of lifestyle modifications and caloric deficit but the results are well worth it. Losing weight dramatically improves quality of life by reducing the severity of or eliminating completely comorbidities of obesity like diabetes, high blood pressure, high cholesterol, heart disease. It also transforms a person's self concept and world view leading to improved mental and emotional health.
It is important to remember that weight loss medications are not a substitute for a healthy lifestyle. They are simply tools. Also, a medication that may work for one person may not be the ideal medication for you. Dr. Stephanie Opusunju understands that when it comes to treating obesity, the best approach is a personalized one.
If you would like to learn more about tirzepatide or other ways to achieve permanent weight loss, please feel free to call us or schedule an appointment with using the online booking tool on this website.